Clinical trials recruiting for CCNE1 Amplification
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Abemaciclib | 2 |
| Fulvestrant | 2 |
| AVZO-021 | 1 |
| Carboplatin | 1 |
| INX-315 | 1 |
| Letrozole | 1 |
| NKT3964 | 1 |
| Palbociclib | 1 |
| Ribociclib | 1 |
| Sacituzumab Govitecan-hziy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 3 |
| Texas | 3 |
| Georgia | 2 |
| Massachusetts | 2 |
| New York | 2 |
| Ohio | 2 |
| Pennsylvania | 2 |
| Virginia | 2 |
| Arkansas | 1 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
Top cities
Self-screener
Recruiting trials
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Study of AVZO-021 in Patients With Advanced Solid Tumors
Related conditions
Trials recruiting for CCNE1 Amplification often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for CCNE1 Amplification trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.